Company Profile - Sensei Biotherapeutics Inc

Introduction

Sensei Biotherapeutics Inc (Sensei) is a clinical stage biopharmaceutical company. The company discovers, develops and commercializes innovative immuno-oncology medicines. Its products include SNS-101, SNS-102, SNS-103 and SNS-401. The company's patented and proprietary technology platform, called SPIRIT, creates novel therapies that target neoantigens or altered self-antigens. Sensei is advancing a new class of immuno-oncology therapies to stimulate the immune system to recognize cancer-specific antigens and attack cancer cells. The company develops and commercializes an integrated set of diagnostics and therapeutics for cancer. It operates in the US. Sensei is headquartered in Gaithersburg, Maryland, the US.